Literature DB >> 10737786

Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.

P L Boyer1, S G Sarafianos, E Arnold, S H Hughes.   

Abstract

We have examined amino acid substitutions at residues 115 and 116 in the reverse transcriptase (RT) of HIV-1. A number of properties were examined, including polymerization and processivity on both DNA and RNA templates, strand displacement, ribonucleotide misincorporation, and resistance to nucleoside analogs. The RT variants Tyr-115-Phe and Phe-116-Tyr are similar to wild-type HIV-1 RT in most, but not all, respects. In contrast, the RT variant Tyr-115-Val is significantly impaired in polymerase activity compared with wild-type RT; however, Tyr-115-Val is able to incorporate ribonucleotides as well as deoxyribonucleotides during polymerization and is resistant to a variety of nucleoside analogs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737786      PMCID: PMC16191          DOI: 10.1073/pnas.97.7.3056

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Analysis of amino insertion mutations in the fingers subdomain of HIV-1 reverse transcriptase.

Authors:  P L Boyer; J Lisziewicz; F Lori; S H Hughes
Journal:  J Mol Biol       Date:  1999-03-05       Impact factor: 5.469

3.  Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.

Authors:  D M Lowe; V Parmar; S D Kemp; B A Larder
Journal:  FEBS Lett       Date:  1991-05-06       Impact factor: 4.124

Review 4.  HIV-1 reverse transcriptase: structure predictions for the polymerase domain.

Authors:  A M Barber; A Hizi; J V Maizel; S H Hughes
Journal:  AIDS Res Hum Retroviruses       Date:  1990-09       Impact factor: 2.205

Review 5.  HIV resistance to reverse transcriptase inhibitors.

Authors:  E De Clercq
Journal:  Biochem Pharmacol       Date:  1994-01-20       Impact factor: 5.858

6.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 7.  Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents.

Authors:  D D Richman
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity.

Authors:  B A Larder; S D Kemp; D J Purifoy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.

Authors:  O Poch; I Sauvaget; M Delarue; N Tordo
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  29 in total

1.  Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.

Authors:  Emmanuele Crespan; Giada A Locatelli; Reynel Cancio; Ulrich Hübscher; Silvio Spadari; Giovanni Maga
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Authors:  Michael E Abram; Andrea L Ferris; Kalyan Das; Octavio Quinoñes; Wei Shao; Steven Tuske; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

Review 3.  Mitochondrial genome maintenance in health and disease.

Authors:  William C Copeland; Matthew J Longley
Journal:  DNA Repair (Amst)       Date:  2014-04-26

4.  Reverse transcriptase incorporation of 1,5-anhydrohexitol nucleotides.

Authors:  K Vastmans; M Froeyen; L Kerremans; S Pochet; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

Review 5.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

6.  Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 7.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04

8.  Multiparameter single-molecule fluorescence spectroscopy reveals heterogeneity of HIV-1 reverse transcriptase:primer/template complexes.

Authors:  P J Rothwell; S Berger; O Kensch; S Felekyan; M Antonik; B M Wöhrl; T Restle; R S Goody; C A M Seidel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

9.  Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.

Authors:  Kamalendra Singh; Bruno Marchand; Karen A Kirby; Eleftherios Michailidis; Stefan G Sarafianos
Journal:  Viruses       Date:  2010-02-11       Impact factor: 5.048

10.  Discrimination against deoxyribonucleotide substrates by bacterial RNA polymerase.

Authors:  Vladimir Svetlov; Dmitry G Vassylyev; Irina Artsimovitch
Journal:  J Biol Chem       Date:  2004-07-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.